Commentary by Giorgio Racagni, Scientific Director ITTBIOMED | EDRA The Milleproroghe Decree is an annual legislative me...
ENEA Tech and Biomedical Invests €3 Million in VST Srl: Advancing Digital Health with Ippocratech® Care
The ENEA Tech and Biomedical Foundation has announced a strategic investment of €3 million in VST Srl (Vital Signal in...
LIFE SCIENCES: presentation all the Projects Approved for Funding Under the Booster for Life Science FVG Notice | Proposal for Further Insights
On December 10th, the event dedicated to the presentation of the projects selected through the first call of the notice ...
Oncology: GSK Acquires U.S. Biotech IDRx
The British pharmaceutical giant GSK has announced the acquisition of the Boston-based biopharmaceutical company IDRx fo...
ADIENNE Pharma & Biotech: A Success Story in Innovation
An Interview with Antonio Francesco Di Naro for the C Suite Feature of Sanità33, by Ludovico Baldessin From pioneering ...
Biotech: Angelini Ventures Leads €20 Million Financing Round for NeumirnaNeumirna Therapeutics: Pioneering RNA-Based Therapies for Neurological Disorders
Neumirna Therapeutics, a Danish biotechnology company specializing in RNA-based therapies for next-generation treatments...